XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning balance $ 777 $ 841
Changes in estimated fair value (156) 73
Payments (119) 0
Other (3) (12)
Fair value, ending balance 499 902
Contingent consideration 499 $ 902
Current liability 139  
Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, ending balance 358  
Contingent consideration $ 358  
Contingent consideration, measurement input, discount rate 0.115